Administration of metrnl delays the onset of diabetes in non-obese diabetic mice-Reference-Cited by-同舟云学术

Administration of metrnl delays the onset of diabetes in non-obese diabetic mice

Published:2021 Issue:2 Volume:68 Page:179-188
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

Yao Zhina¹,Lin Peng²,Wang Chuan²,Wang Kexin³,Sun Yu²

Affiliation:

1. Center for Reproductive Medicine, Reproductive Hospital Affiliated with Shandong University, Jinan, 250012, Shandong, PR China

2. Department of Endocrine, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, PR China

3. Department of General Surgery, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, PR China

Publisher

Japan Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.jstage.jst.go.jp/article/endocrj/68/2/68_EJ20-0351/_pdf

Reference36 articles.

1. 1 Copenhaver M, Hoffman RP (2017) Type 1 diabetes: where are we in 2017? Transl Pediatr 6: 359–364.

2. 2 Skowera A, Ellis RJ, Varela-Calviño R, Arif S, Huang GC, et al. (2008) CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope. Version 2. J Clin Invest 118: 3390–3402.

3. 3 Fousteri G, Dave A, Bot A, Juntti T, Omid S, et al. (2010) Subcutaneous insulin B: 9-23/IFA immunisation induces Tregs that control late-stage prediabetes in NOD mice through IL-10 and IFN gamma. Diabetologia 53: 1958–1970.

4. 4 Michels AW, von Herrath M (2011) 2011 Update: antigen-specific therapy in type 1 diabetes. Curr Opin Endocrinol Diabetes Obes 18: 235–240.

5. 5 Thrower SL, James L, Hall W, Green KM, Arif S, et al. (2009) Proinsulin peptide immunotherapy in type 1 diabetes: report of a first-in-man Phase I safety study. Clin Exp Immunol 155: 156–165.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metrnl: a promising biomarker and therapeutic target for cardiovascular and metabolic diseases;Cell Communication and Signaling;2024-08-05

2. The Plasma Levels of Protein Adiponectin (AdipoQ) and Meteorin-Like (Metrnl) in Newly Diagnosed Type 2 Diabetes Mellitus;Diabetes, Metabolic Syndrome and Obesity;2024-07

3. Homotherapy for heteropathy: Interleukin‐41 and its biological functions;Immunology;2024-04-09

4. Novel single nucleotide polymorphism (rs1600485907) of IL-41 gene associated with systemic lupus erythematous;Asia Pacific Journal of Molecular Biology and Biotechnology;2023-10-22

5. Endothelial METRNL determines circulating METRNL level and maintains endothelial function against atherosclerosis;Acta Pharmaceutica Sinica B;2023-04